Clinical Trials · NCT00375492
Effect on Weight Loss of Exenatide Versus Placebo
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 196
- Start date
- Sep 2006
- Locations
- 10 sites, United States
- Primary endpoint
- Change From Baseline in Body Weight